Skip to main content
An official website of the United States government
Español

treosulfan

(TREE-oh-SUL-fan)
A drug given with fludarabine phosphate before a donor hematopoietic stem cell transplant in adults and children aged 1 year and older with acute myeloid leukemia or myelodysplastic syndrome. It is also being studied in the treatment of other types of cancer. Treosulfan may kill cancer cells by damaging their DNA and stopping them from dividing. It is a type of alkylating agent. Also called Grafapex.
Search NCI's Dictionary of Cancer Terms